Feedback / Questions
olvimulogene nanivacirepvec (GL-ONC1) - Genelux
https://www.globenewswire.com/news-release/2025/11/05/3182008/0/en/Genelux-Corporation-Reports-Third-Quarter-2025-Financial-Results-and-Provides-General-Business-Updates.html
Nov 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next